Karen Boezi

Karen Boezi is the Chief Operating Officer (COO) at Thirona Bio, a biopharmaceutical company specializing in developing organ-selective drugs that target TGF-β for treating fibrotic diseases such as skin and lung fibrosis and certain cancers.13 With over 30 years of experience in the biopharmaceutical sector, Boezi has held various leadership roles, including serving as the CEO of Redwood Bioscience, where she successfully led the company through its acquisition by Catalent.24

Her career highlights include:

• Leadership Roles: Prior to her tenure at Thirona Bio, she was a founding partner at Thomas, McNerney & Partners, a venture capital firm focused on healthcare technology. She has also been involved in launching multiple companies and investing in numerous successful biopharmaceutical ventures.23
• Educational Background: Boezi graduated Phi Beta Kappa with a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.14
• Investment and Advisory Roles: In addition to her operational roles, she is an angel investor and advisor to several biopharmaceutical startups, contributing her expertise to emerging companies in the industry.24

Overall, Karen Boezi is recognized for her significant contributions to the field of biopharmaceuticals, particularly in the areas of drug development and venture capital.